Paediatric Acute Respiratory Distress Syndrome
Also known as: Pediatric Acute Respiratory Distress Syndrome, PARDS
Paediatric acute respiratory distress syndrome is acute hypoxaemic respiratory failure with diffuse lung inflammation, onset within 7 days of a known insult, and new infiltrates on chest imaging that cannot be fully explained by heart failure or fluid overload.
Severity is graded by the oxygenation index, calculated as the mean airway pressure times FiO2 times 100, divided by PaO2 in mmHg: mild 4 to under 8, moderate 8 to under 16, and severe 16 or over.
When oxygenation is only assessed by pulse oximetry, the oxygen saturation index is used. In children with non-invasive support, a PaO2 to FiO2 ratio of 300 or under with full face mask CPAP or bilevel ventilation at 5 cmH2O or more defines at risk or mild disease.
It accounts for about 1 to 3% of paediatric intensive care admissions. Mortality is about 10 to 20% overall and higher in severe disease and in immunocompromised children.
Causes are pneumonia (the commonest, often viral), sepsis, aspiration, near drowning, trauma, pancreatitis, transfusion related lung injury and inhalation injury.
Pathophysiology.
Injury to alveolar epithelium and endothelium causes increased permeability, protein rich oedema, surfactant dysfunction and neutrophil driven inflammation. Alveoli collapse and fill with fluid, producing shunt and reduced compliance.
Ventilation can worsen injury through overdistension and cyclic collapse (ventilator induced lung injury).













